Lightnews — Scholar-powered news

LightNews

PrECOG

@precogonc.bsky.social

37 followers 59 following 38 posts

Innovative cancer research studies developed through industry partnerships and networks. Supporting ECOG-ACRIN's efforts to advance cancer care

Posts Media Videos Starter Packs

PrECOG @precogonc.bsky.social · 4d

Kudos to the following institutions for enrolling their first patients in #RealWorldData #PatientRegistry PrE1702: Sibley Memorial Hospital, Good Samaritan University Hospital, and Northwestern University! More info here: bit.ly/pre1702-study #LCSM #RWD #RWE

ClinicalTrials.gov

PrECOG @precogonc.bsky.social · 16d

Kudos to The Valley Hospital (Luckow Pavilion) for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Sep 10

Kudos to Aurora Saint Luke’s Medical Center for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Aug 29

Kudos to John H. Stroger, Jr. Hospital of Cook County for enrolling their 1st patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in pts not in a #ClinicalTrial. bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Aug 29

University of Wisconsin Carbone Cancer Center is now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in pts not in a #ClinicalTrial. bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Aug 20

Sibley Memorial Hospital is now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in pts not in a #ClinicalTrial. bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Aug 19

Kudos to The University of Alabama at Birmingham for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. More: bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

Reposted by PrECOG

ECOG-ACRIN Cancer Research Group @eaonc.bsky.social · Aug 5

ICYMI: Check out our round-up of recently published @eaonc.bsky.social and @precogonc.bsky.social research results. More here ➡️ bit.ly/july25research

#ClinicalTrials #BreastCancer #CancerControl #CancerSurvivorship #HeadandNeck #LungCancer #Melanoma

PrECOG @precogonc.bsky.social · Jul 28

Great work to Atlantic Health System for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. More: bit.ly/4hyZUue #LCSM

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Jul 8

Kudos to The Cancer Institute at Saint Francis Hospital for enrolling their 1st patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in pts not in a #ClinicalTrial. bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Jul 8

Good Samaritan University Hospital is now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. Learn more: bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Jun 24

Kudos to SUNY Upstate Medical University for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. More: bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Jun 13

Kudos to Allegheny General Hospital for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. Learn more: bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Jun 13

The Cancer Institute at St. Francis Hospital & UNC Pardee Cancer Center are now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in pts not in a #ClinicalTrial. bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Jun 11

Gundersen Lutheranis now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. Learn more: bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Jun 3

Montefiore Medical Center is now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. Learn more: bit.ly/pre1702-study

PrECOG @precogonc.bsky.social · May 29

Carle Cancer Institute is enrolling pts in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. bit.ly/pre1702-study

PrECOG @precogonc.bsky.social · May 20

O'Neal Comprehensive Cancer Center at UAB is now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in pts not in a #ClinicalTrial. Learn more: bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · May 9

Great work to @penncancer.bsky.social for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in pts not in a #ClinicalTrial. Learn more: bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Apr 28

Great work to Mercyhealth Hospital and Cancer Center Janesville for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in pts not in a #ClinicalTrial. Learn more: bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Apr 28

Aurora NCORP and Northwestern University are now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. Learn more: bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Apr 22

Great work to Regions Hospital for enrolling their first patient in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in pts not in a #ClinicalTrial. Learn more: bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Apr 16

Allegheny General Hospital is now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in patients not in a #ClinicalTrial. Learn more: bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Apr 9

Atlantic Health Consortium Community Oncology Research Program is enrolling pts in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in pts not in a #ClinicalTrial. bit.ly/4hyZUue

Spotlight on Real-World Data Capture: The PrE1702 Registry Study in Lung Cancer

This major new initiative is a unique opportunity for researchers and patients to help build an important real-world data registry of patients with EGFR-mutated non-small cell lung cancer

PrECOG @precogonc.bsky.social · Apr 7

Kudos to Greater Baltimore Medical Center for enrolling their first patient! ⬇️

PrECOG @precogonc.bsky.social · Mar 31

Greater Baltimore Medical Center is now enrolling patients in #RealWorldData #PatientRegistry PrE1702! This study is evaluating how well osimertinib +/- chemo/IO works to control EGFR+ #LungCancer in pts not in a #ClinicalTrial. Learn more: bit.ly/4hyZUue